MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the third quarter of 2023. There was a double-digit increase in service revenues. Total revenues remained broadly unchanged at $2.06 million in the September quarter. An increase in service revenues was offset by a decline in product revenues. Net loss […]

January 17, 2024 1 min read

“
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the third quarter of 2023. There was a double-digit increase in service revenues. Total revenues remained broadly unchanged at $2.06 million in the September quarter. An increase in service revenues was offset by a decline in product revenues. Net loss […]
· January 17, 2024

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the third quarter of 2023. There was a double-digit increase in service revenues.

Trxade Q3 2023 earnings infographic

Total revenues remained broadly unchanged at $2.06 million in the September quarter. An increase in service revenues was offset by a decline in product revenues.

Net loss attributable to Trxade Health was $3.53 million or $0.07 per share in the third quarter, compared to a loss of $0.53 million or $0.57 per share in the same period of last year.

Total registered users on the TRxADE platform increased by 870 or 6.17% compared to September 2022. For the nine months ended September 2023, new registrations were 196, compared to 296 for the same period in 2022. The company had a total of around 14,900+ registered members at the end of the quarter.